Preferential phosphorylation of focal adhesion kinase tyrosine 861 is critical for mediating an anti-apoptotic response to hyperosmotic stress

J Biol Chem. 2007 Apr 6;282(14):10370-9. doi: 10.1074/jbc.M607780200. Epub 2007 Feb 8.

Abstract

The results presented here demonstrate that focal adhesion kinase (FAK) Tyr-861 is the predominant tyrosine phosphorylation site stimulated by hyperosmotic stress in a variety of cell types, including epithelial cell lines (ileum-derived IEC-18, colon-derived Caco2, and stomach-derived NCI-N87), FAK null fibroblasts re-expressing FAK, and Src family kinase triple null fibroblasts (SYF cells) in which c-Src has been restored (YF cells). We show that hyperosmotic stress-stimulated FAK phosphorylation in epithelial cells is inhibited by Src family kinase inhibitors PP2 and SU6656 and that it does not occur in SYF cells. Unexpectedly, hyperosmotic stress-induced phosphorylation of FAK at Tyr-397, Tyr-576, and most dramatically at Tyr-861 was completely insensitive to the F-actin-disrupting agents, latrunculin A and cytochalasin D. Finally, we show that in FAK null cells exposed to hyperosmotic stress or growth factor withdrawal, re-expression of wild type FAK restored cell survival, whereas re-expression of FAK mutated from tyrosine to phenylalanine at position 861 (FAKY861F) did not. Our results indicate that FAK Tyr-861 phosphorylation is required for mammalian cell survival of hyperosmotic stress. Furthermore, the results suggest that FAK is an upstream regulator (rather than downstream effector) of F-actin reorganization in response to hyperosmotic stress. We propose that FAK/c-Src bipartite enzyme is a sensor of cytoplasmic shrinkage, and that the phosphorylation on FAK Tyr-861 by Src and subsequent reorganization of F-actin can initiate an anti-apoptotic signaling pathway that protects cells from hyperosmotic stress.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Actins / antagonists & inhibitors
  • Actins / metabolism
  • Amino Acid Substitution
  • Apoptosis* / drug effects
  • Apoptosis* / genetics
  • Bridged Bicyclo Compounds, Heterocyclic / pharmacology
  • Caco-2 Cells
  • Cell Survival / drug effects
  • Cytochalasins / pharmacology
  • Cytoplasm / enzymology
  • Cytoplasm / genetics
  • Fibroblasts / enzymology*
  • Focal Adhesion Kinase 1 / genetics
  • Focal Adhesion Kinase 1 / metabolism*
  • Humans
  • Indoles / pharmacology
  • Mutation, Missense
  • Osmotic Pressure / drug effects
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / pharmacology
  • Protein Processing, Post-Translational* / drug effects
  • Protein Processing, Post-Translational* / genetics
  • Pyrimidines / pharmacology
  • Signal Transduction* / drug effects
  • Signal Transduction* / genetics
  • Sulfonamides / pharmacology
  • Thiazolidines / pharmacology
  • Tyrosine / genetics
  • Tyrosine / metabolism
  • src-Family Kinases / antagonists & inhibitors
  • src-Family Kinases / metabolism

Substances

  • AG 1879
  • Actins
  • Bridged Bicyclo Compounds, Heterocyclic
  • Cytochalasins
  • Indoles
  • Protein Kinase Inhibitors
  • Pyrimidines
  • SU 6656
  • Sulfonamides
  • Thiazolidines
  • cytochalasin A
  • Tyrosine
  • Focal Adhesion Kinase 1
  • PTK2 protein, human
  • src-Family Kinases
  • latrunculin A